Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Podcast: FDA's Tezak Looks Ahead On Next-Gen Sequencing Regs

This article was originally published in The Gray Sheet

Executive Summary

FDA's Zivana Tezak was pleasantly surprised at the high level of complexity that stakeholders brought to a recent meeting on using curated databases to support next generation sequencing cancer tests. The conversations are a good jumping off point for the agency as it plans to hold back-to-back workshops on NGS in November, she said in a podcast interview with "The Gray Sheet."